SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roudy who started this subject7/13/2001 2:20:36 AM
From: Skywatcher   of 1762
 
A sad day due to the usual analyst screw up...nothing to do with stockholders and the company never said a thing about the estimates of more than 200 Mill for the quarter, but beyond belief is the usual dump on a stock that is making great revs and money...just think they are gonna meet the street .15 with $25 million less revs than anticipated....
those clowns who call themselves analysts are amazing, and Merrill Lynch was selling the crap out of this stock all day especially around the 53 mark. Disgusting.
With all the stuff in the pipeline and this drug making almost a billion a year, it sells off in a heart beat while it looks like we're back in 2000 with stocks that lose the most gain the most, and those that are kicking butt and don't hit a figure as unrealistic as 215 mill get dumped.
CC
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News